Danielle M. Brander
@dbranderMDtranslational oncologist at Duke Cancer Institute / director CLL & Lymphoma research program / views and tweets are my own
Similar User
@UjjaniC
@DrMDavids
@jeff_sharman
@CllSociety
@ASkarbnik
@CraigMoskMD
@DanilovLab
@drjoannarhodes1
@SoniSmithMD
@DebbieMStephens
@RoschewskiMD
@mshadman
@DrDanPersky
@AdamKittai
@KrishPatelMD
CME Opportunity: Join #DukeDebates2024, presented by #DukeCancerNetwork in collaboration with @DukeCancer April 12-14, 2024, Hilton Head, SC Register here: bit.ly/DukeDebates CME credit available. Earn up to 12 MOC Part 2 points. #DukeCancerInstitute #MedEd
Ask your doctor if you are considered high risk by the CLLIPI score. If so, you may qualify for this exciting study. #CLL @SWOG @BrianHill_MDPhD @mshadman @anthonymatomd @dbranderMD @DanilovLab
Venetoclax + obinutuzumab combo is approved as front-line tx for pts w #CLL. Can intervening early w this combo vs waiting for symptoms lengthen survival for pts w high-risk (CLL-IPI of 4+) CLL or small #lymphocytic #lymphoma? @SWOG S1925 trial. SWOG.org/clinical-trial… @NRGonc
Outstanding commentary by @DebbieMStephens from @huntsmancancer on the recent publication on the ELEVATE-RR study comparing ibrutinib and acalabrutinib in R/R CLL in @JCO_ASCO ascopubs.org/doi/abs/10.120…
We are making progress in high-risk #CLL. Durable Remissions Following Combined Targeted Therapy in Patients with CLL Harboring TP53 Deletions and/or Mutations | Blood | American Society of Hematology #leusm #leukemia @UKKoeln ashpublications.org/blood/article/…
Just out - our multicenter effort to dissect comorbidities in CLL @mshadman @DrDanPersky @dbranderMD @matthew_mei @jonathonbcohen @KrishPatelMD @BrianHill_MDPhD @DebbieMStephens clincancerres.aacrjournals.org/content/early/…
Thanks to the @CllSociety for all you do for our patients. Happy New Year!
To keep our CLL patients healthy, we use our Brains! 100s of ground-breaking CLL-focused clinical trials & 1000s of hours of compassionate clinical care inform #CLLSociety’s Med Ad Board. Thank you! @DrMDavids @dbranderMD @DebbieMStephens @ASkarbnik bit.ly/2KpJ7A5
Important MURANO tox ax @anthonymatomd @jeff_sharman et al 28% premature d/c VR<2y ⬇️ PFS in prem d/c ven for any reason (PD excluded;p<0.0001)+due to AE Interrupt for AE 69% / dose ⬇️ 23% both no impact on PFS/OS Tox mx+continued Rx important for VenR PFS outcome #CLL #lymsm
#ASH20 poster by @LindsayReinMD @DukeHMCT @dukemedicine @DukeCancer Phase I trial incorporating NK cells for patients w/ #CML & MRD after TKI therapy. #leusm bit.ly/3osWQ7x
There may not have been an official ASH run this year, but anyone else still get in their #FauciFour ? If daily running is the secret to Dr Fauci leading the nation through this chaos, may I never stop. Also, the San Diego skyline has nothing on my view. #IRunForASH
To teach is to learn, twice And thankful for this opportunity from #ASH20, twice - to learn from so many others but also to work on this with an amazing fellow @DukeFellows, Dr Ashley Hanlon @amilliga, that has taught me so much and co authored this chapter #dukefamily
To keep our CLL patients healthy, we use our Brains! 100s of ground-breaking CLL-focused clinical trials & 1000s of hours of compassionate clinical care inform #CLLSociety’s Med Ad Board. Thank you! @DrMDavids @dbranderMD @DebbieMStephens @ASkarbnik bit.ly/2KpJ7A5
We are so excited to welcome @_joycehwang @andrewpeseski @FahminB_MDPhD Drs. Kathrine DiNardo, Cameron Oswalt, Grayce Selig, and Cameron Wood to the Duke Heme/Onc Fellowship Program! We are so excited to have you join our wards and clinics in July 2021! @DukeCancer @dukemedicine
Intolerance is a failure of the medication for that given patient, patients don’t fail therapy. Grateful to be a part of this collaborative effort @DukeHMCT and for all trials aimed at the unmet need of intolerance. @anthonymatomd @AndreaSitlinger and many others
To keep our CLL patients healthy, we use our Brains! 100s of ground-breaking CLL-focused clinical trials & 1000s of hours of compassionate clinical care inform #CLLSociety’s Med Ad Board. Thank you! @DrMDavids @dbranderMD @DebbieMStephens @ASkarbnik bit.ly/2KpJ7A5
Please see our publication of the largest cohort of patients #Hodgkin transformation in #CLL patients. haematologica.org/article/view/h… Planning more research in this patient population. Thanks for a great collaborative effort. @huntsmancancer @UUtah @UofUHealth
Outcome of #Hodgkin arising from #CLL. collaboration led by @DebbieMStephens haematologica.org/article/view/h… @dbranderMD @DrMDavids @anthonymatomd @fredhutch @SeattleCCA
🎉🎉 Congratulations to @BarbAlexanderMD, who will be the new president of @IDSAInfo "The critical role of ID physicians & scientists has never been more apparent as it is today." idsociety.org/news--publicat…
every point exactly, @JasAWebb - easy to feel defeated hearing this news, but will take that energy and use it to inspire action towards the many challenges that face us...
To keep our CLL patients healthy, we use our Brains! 100s of ground-breaking CLL-focused clinical trials & 1000s of hours of compassionate clinical care inform #CLLSociety’s Med Ad Board. Thank you! @DrMDavids @dbranderMD @DebbieMStephens @ASkarbnik bit.ly/2KpJ7A5
This is consistent with my observation in the hospital now: milder forms of #SARSCoV2 infections. #Masks may reduce the viral dose during contact with infected persons: Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine | NEJM nejm.org/doi/full/10.10…
United States Trends
- 1. Hunter 1,18 Mn posts
- 2. tannie 29,7 B posts
- 3. Yeontan 82,4 B posts
- 4. #Brokeflyday 3.022 posts
- 5. Josh Allen 49,9 B posts
- 6. 49ers 56,3 B posts
- 7. Bills 164 B posts
- 8. Niners 11 B posts
- 9. Burisma 42,4 B posts
- 10. #BaddiesMidwest 21 B posts
- 11. Dolly 15,4 B posts
- 12. Montas 3.748 posts
- 13. Purdy 9.023 posts
- 14. Big Guy 74,2 B posts
- 15. Manafort 13,9 B posts
- 16. Japon 18,3 B posts
- 17. Roger Stone 12,8 B posts
- 18. #RHOP 6.920 posts
- 19. Manaea N/A
- 20. Good for Joe 33,3 B posts
Who to follow
-
Chaitra Ujjani, MD
@UjjaniC -
Matthew Davids, MD, MMSc
@DrMDavids -
Jeff Sharman
@jeff_sharman -
CLL Society Inc.
@CllSociety -
Alan Skarbnik
@ASkarbnik -
Craig Moskowitz, MD
@CraigMoskMD -
Danilov Lab
@DanilovLab -
Joanna M. Rhodes, MD, MSCE
@drjoannarhodes1 -
Soni Smith MD
@SoniSmithMD -
Deborah Stephens
@DebbieMStephens -
Mark Roschewski
@RoschewskiMD -
Mazyar Shadman, MD MPH
@mshadman -
Daniel Persky, MD
@DrDanPersky -
Adam Kittai
@AdamKittai -
Krish Patel
@KrishPatelMD
Something went wrong.
Something went wrong.